leriglitazone

oral PPAR_ agonist for CNS diseases

Ph. II and III ongoing for AMN and cALD

one of the metabolites of pioglitazone

Science Translational Medicine

Minoryx Therapeutics S.L., Barcelona, ES

14. The Minoryx peroxisome proliferator-activated receptor gamma (PPAR_) agonist, leriglitazone, is one of the several metabolites of pioglitazone, a member of the thiazolidinedione (glitazone) drug class for diabetes. It…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks